Trials / Conditions / Mild to Moderate Ulcerative Colitis
Mild to Moderate Ulcerative Colitis
6 registered clinical trials studyying Mild to Moderate Ulcerative Colitis.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | A Study of SPH3127 in the Treatment of Mild to Moderate Ulcerative Colitis NCT05770609 | Shanghai Pharmaceuticals Holding Co., Ltd | Phase 2 |
| Completed | Study to Assess Effectiveness of Therapy Timely Adjustment Based on Self-monitoring in Patients Suffering From NCT04340895 | Ferring Pharmaceuticals | N/A |
| Completed | Once Versus Twice Daily Mesalamine to Induce Remission in Pediatric Ulcerative Colitis NCT01201122 | Wolfson Medical Center | Phase 4 |
| Completed | Oral Ciclosporin for Colonic Release in Ulcerative Colitis (CyCol™) NCT01033305 | Sigmoid Pharma | Phase 2 |
| Unknown | Safety and Activity of ORE1001 in Subjects With Ulcerative Colitis NCT01039597 | Ore Pharmaceuticals, Inc. | Phase 1 / Phase 2 |
| Completed | A BE Study Comparing Mesalamine 400 mg to ASACOL® 400 mg in Patients With Mild To Moderately Active Ulcerative NCT01045018 | EMET Pharmaceuticals, LLC | Phase 3 |